Human recombinant neutralizing antibodies against Hantaan virus G2 protein

Virology

Volumn 308, Issue 1, 2003, Pages 64-73

  Koch, Joachim ^a,e   Liang, Mifang ^a,b   Queitsch, Iris ^c   Kraus, Annette A ^d   Bautz, Ekkehard K F ^a,c  

^a Hantavirus Forschungsstelle H   (Germany)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

Epitope mapping; Hantavirus; Neutralizing antibodies; Recombinant Antibodies

Indexed keywords

EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN G2; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; DOBRAVA VIRUS; EPITOPE MAPPING; HANTAVIRUS; HOST CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; PUUMALA VIRUS; SEOUL VIRUS; SEQUENCE ANALYSIS; SERODIAGNOSIS; TECHNOLOGY; VERO CELL; VIRUS ENVELOPE; VIRUS PARTICLE;

DOBRAVA VIRUS; HANTAAN VIRUS; HANTAVIRUS; PUUMALA VIRUS; SEOUL VIRUS; UNIDENTIFIED BACULOVIRUS;

EID: 0037473316     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00094-6     Document Type: Article

References (40)

1. Antoniadis A., LeDuc J.W., Acritidis N., Alexiou-Daniel S., Kyparissi A., Saviolakis G.A. Hemorrhagic fever with renal syndrome in Greece clinical and laboratory characteristics . Rev. Infect. Dis. 11:(Suppl. 4):1989;891-896.
2. Arikawa J., Schmaljohn A.L., Dalrymple J.M., Schmaljohn C.S. Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J. Gen. Virol. 70:1989;615-624.
3. Arikawa J., Yao J.S., Yoshimatsu K., Takashima I., Hashimoto N. Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies. Arch. Virol. 126:1992;271-281.
4. Avsic-Zupanc T., Toney A., Anderson K., Chu Y.K., Schmaljohn C. Genetic and antigenic properties of Dobrava virus a unique member of the Hantavirus genus, family Bunyaviridae . J. Gen. Virol. 76:1995;2801-2808.
5. Barbas C.F. III, Kang A.K., Lerner R.A., Benkovic S.J. Assembly of combinatorial antibody libraries on phage surfaces the gene III site . Proc. Natl. Acad. Sci. USA. 88:1991;7978-7982.
6. Barbas C.F. III, Lerner R.A. Combinatorial immunoglobulin on the surface of phage (Phabs) rapid selection of antigen-specific Fabs . Burton R., Lerner R. Methods: a Companion to Methods in Enzymology. Vol. 2, New Techniques in Antibody Generation. 1991;119-124 Academic Press, San Diego.
7. Frank R., Schneider-Mergener J. SPOT synthesis - scope of applications. Koch J., Mahler M. Peptide Arrays on Membrane Supports. 2002;Springer Verlag, Heidelberg.
8. Gavrilovskaya I.N., Shepley M., Shaw R., Ginsberg M.H., Mackow E.R. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. USA. 95:1998;7074-7079.
9. Griot C., Gonzalez-Scarano F., Nathanson N. Molecular determinants of the virulence and infectivity of California serogroup Bunyaviruses. Annu. Rev. Microbiol. 47:1993;117-138.
10. Guttieri M.C., Bookwalter C., Schmaljohn C. Expression of a human, neutralizing monoclonal antibody specific to Puumala virus G2-protein in stably-transformed insect cells. J. Immunol. Methods. 246:2000;97-108.
11. Kim T.Y., Choi Y., Cheong H.S., Choe J. Identification of a cell surface 30 kDa protein as a candidate receptor for Hantaan virus. J. Gen. Virol. 83:2002;767-773.
12. Heiskanen T., Lundkvist A., Soliymani R., Koivunen E., Vaheri A., Lankinen H. Phage-displayed peptides mimicking the discontinuous neutralization sites of puumala Hantavirus envelope glycoproteins. Virology. 262:1999;321-332. doi:10.1006/viro.1999.9930.
13. Kabat, E.A., Wu, T.T., Reid-Miller, M., Perry, H.M., Gottesman, K.S., 1987. Sequences of proteins of immunological interest, U.S. Dept. of Health and Human Services, U.S. Government Printing Office, Washington, DC.
14. Kang A.S., Burton D.R., Lerner R.A. Combinatorial immunoglobulin libraries in phage lambda. Burton R., Lerner R. Methods: A Companion to Methods in Enzymology. Vol. 2, New Techniques in Antibody Generation. 1991;111-118 Academic Press, San Diego.
15. Heider H., Ziaja B., Priemer C., Lindkvist Å., Neyts J., Krüger D.H., Ulrich R. A chemiluminescent detection method of hantaviral antigens in neutralisation assays and inhibitor studies. J. Virol. Methods. 96:2001;17-23.
16. Koch J., Dübel S. Generation of antibody libraries from human donors. Kontermann R., Dübel S. Antibody Engineering. 2001;Springer Verlag, Heidelberg.
17. Koch J., Mahler M. Peptide Arrays on Membrane Supports. 2002;Springer Verlag, Heidelberg.
18. Lee H., Baek L., Johnson K. Isolation of Hantaan virus, the ethiologic agent of Korean hemorrhagic fever from wild urban rats. J. Infect. Dis. 146:1982;638-644.
19. Lee, H., Dalrymple, J., Eds. 1989. Manual of hemorrhagic fever with renal syndrome. WHO Collaborating Center for Virus Reference and Research, Seoul.
20. Lee H.W., Lee P.W., Baek L.J., Song C.K., Seong I.W. Intraspecific transmission of Hantaan virus, ethiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius. Am. Soc. Trop. Med. Hyg. 30:1981;1106-1112.
21. Lee H.W., Lee P.W., Johnson K.M. Isolation of the ethiologic agent of Korean haemorrhagic fever. J. Infect. Dis. 137:1978;298-308.
22. Liang M., Chu Y.K., Schmaljohn C. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus. Virology. 217:1996;262-271. doi:10.1006/viro.1996.0113.
23. Liang M., Dübel S., Li D., Queitsch I., Li M., Bautz E.K.F. Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. J. Immunol. Meth. 247:2001;119-130.
24. Liang M., Guttieri M., Lundkvist A., Schmaljohn C. Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus. Virology. 235:1997;252-260. doi:10.1006/viro.1997.8695.
25. Liang, M., Mahler, M., Koch, J., Ji, Y., Li, D., Schmaljohn, C., Bautz, E.K.F., 2003. Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain. J. Med. Virol. 69, 99-107.
26. Mackow E.R., Gavrilovskaya I.N. Cellular receptors and hantavirus pathogenesis. Curr. Top. Microbiol. Immunol. 256:2001;91-115.
27. Nagai T., Tanishita O., Takahashi Y., Yamanouchi T., Domae K., Kondo K., Dantas J.R. Jr., Takahashi M., Yamanishi K. Isolation of haemorrhagic fever with renal syndrome virus from leukocytes of rats and virus replication in cultures of rat and human macrophages. J. Gen. Virol. 66:1985;1271-1278.
28. Niklasson B., Le Duc J. Isolation of the nephropathia epidemica agent in Sweden. Lancet. 1:1984;1012-1013.
29. Parmley S.F., Smith G.P. Antibody-selectable filamentous fd phage vectors affinity purification of target genes . Gene. 73:1988;305-318.
30. Salonen E.M., Parren P.W., Graus Y.F., Lundkvist A., Fisicaro P., Vapalahti O., Kallio-Kokko H., Vaheri A., Burton D.R. Human recombinant Puumala virus antibodies cross-reaction with other hantaviruses and use in diagnostics . J. Gen. Virol. 79:1998;659-665.
31. Schenerman M.A., Hope J.N., Kletke C., Singh J.K., Kimura R., Tsao E.I., Folena-Wasserman G. Comparability testing of a humanized monoclonal antibody (Synagis) to support cell line stability, process validation, and scale-up for manufacturing. Biologicals. 27:1999;203-215. doi:10.1006/biol.1999.0179.
32. Schmaljohn C.S., Arikawa J., Hasty S.E., Rasmussen L., Lee H.W., Lee P.W., Dalrymple J.M. Conservation of antigenic properties and sequences encoding the envelope proteins of prototype Hantaan virus and two virus isolates from Korean haemorrhagic fever patients. J. Gen. Virol. 69:1988;1949-1955.
33. Schmaljohn C.S., Chu Y.K., Schmaljohn A.L., Dalrymple J.M. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J. Virol. 64:1990;3162-3170.
34. Schmaljohn C.S., Dalrymple J.M. Analysis of Hantaan virus RNA evidence for a new genus of bunyaviridae . Virology. 131:1983;482-491.
35. Schmaljohn C., Hjelle B. Hantaviruses a global disease problem . Emerg. Infect. Dis. 3:1997;95-104.
36. Shi X.H., Hang C.S., Song G., Liang M. Baculovirus expression of M genome segment of Hantaan virus and immunogenic studies of the expressed glycoproteins. Chin. J. Virol. 214:1995;208-214.
37. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice . Nucleic Acids Res. 22:1994;4673-4680.
38. Wells R.M., Sosa Estani S., Yadon Z.E., Enria D., Padula P., Pini N., Mills J.N., Peters C.J., Segura E.L. An unusual hantavirus outbreak in southern Argentina person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia . Emerg. Infect. Dis. 3:1997;171-174.
39. Yao J.S., Kariwa H., Takashima I., Yoshimatsu K., Arikawa J., Hashimoto N. Antibody-dependent enhancement of hantavirus infection in macrophage cell lines. Arch. Virol. 122:1992;107-118.
40. Zhang X.K., Takashima I., Hashimoto N. Characteristics of passive immunity against hantavirus infection in rats. Arch. Virol. 105:1989;235-246.